CCN2 and diabetic kidney disease: Increased expression of CTGF in the kidneys has been observed in various clinical and pre-clinical models, including models of diabetic nephropathy, hypertensive nephrosclerosis, crescentic glomerulonephritis, and chronic allograft nephropathy15–20, 32.